Sat.Aug 27, 2022 - Fri.Sep 02, 2022

article thumbnail

The futility of banner ads

World of DTC Marketing

Digital ad spending in the industry will reach $15.84 billion in 2022. Although growth in digital budgets is slowing, we estimate the category will see nearly $20 billion in spending in 2024. For every $1 million invested in online banner ads, just 0.1%, or $1,000, derives value for brands, resulting in $999,000 wasted by brands. So why is pharma wasting so much money?

article thumbnail

Episode 97 – Trade Shows and Events, What’s changed and what you should do. Part 1

Medical Device Success

Reading time: 2 – 4 minutes. I am honored to have two event planning experts, Lauren Dustman, Senior Manager, Global Events at Hyperfine and Kimberly Stanséll, Meeting, Trade Show and Event Strategy Consultant to guide us today in this conversation. Combined, these ladies manage about 100 shows and events annually. Today’s episode is the first of two episodes about medical trade shows.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 rules rural health systems must follow for virtual care success

MedCity News

Rural health systems should be the champions of virtual care delivery, according to Jim Weinstein, Microsoft’s senior vice president of health equity and innovation. He and Sheri Dodd, vice president and general manager of Medtronic Care Management Services, laid out recommendations for rural providers to establish scalable and sustainable virtual care programs during a conference held last week by Sanford Health.

article thumbnail

Quiet Quitting Isn’t the Problem. Your Managers Are.

Integrity Solutions

One of the first big workforce catchphrases to go viral after the onset of the pandemic was “The Great Resignation,” as employees began to reevaluate their careers and leave their jobs in record numbers. This max exodus of talent may be slowing down a bit, but it’s far from over. More than two years later, even with the threat of a recession looming in the background, companies continue to struggle with finding talent to fill open positions.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

DTC as part of an integrated strategy

World of DTC Marketing

DTC marketers spend a lot of time and money gaining insights into patients and caregivers. That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. A sales representative for a biotech company shared information with oncologists about patients’ attitudes towards treatment options, including the company’s brand.

article thumbnail

Novartis extends Kaiku digital patient monitoring partnership

pharmaphorum

Kaiku Health’s year-old alliance with Novartis to develop a digital patient monitoring and management (DPPM) system for patients with melanoma is being extended, according to the two partners. The original agreement last year focused on melanoma patients who are receiving BRAF/MEK combination therapies – specifically Novartis’ Tafinlar (dabrafenib) and Mekinist (trametinib) drugs – and has resulted in the development of a digital module tailored to their needs.

Patients 111

More Trending

article thumbnail

Novo Nordisk agrees to acquire biopharma firm Forma for $1.1bn

Pharmaceutical Technology

Novo Nordisk has signed a definitive agreement for the acquisition of clinical-stage biopharmaceutical firm Forma Therapeutics for $20 for each share in cash or a total equity price of $1.1bn. Forma focuses on researching, developing and marketing new therapies for patients with sickle cell disease (SCD), rare hematologic diseases and cancers. Through the acquisition, Novo Nordisk plans to boost its presence in sickle cell disease and rare blood disorders.

Biopharma 105
article thumbnail

Life expectancy declines again

World of DTC Marketing

According to STAT News, “Americans born in 2021 can expect to live for just 76.1 years — the lowest life expectancy has been since 1996, according to a new government analysis published Wednesday. This is the biggest two-year decline — 2.7 years in total — in almost 100 years.” It’s only going to get worse too. The Covid-19 pandemic is the primary cause of the decline, but we are ignoring another statistic.

Food 176
article thumbnail

Digital Thread Solutions Can Speed Scale-up and Shorten Time to Market for Pharma

PM360

In the pharmaceutical business, as with any other business, you can’t market what you haven’t brought to market. It’s no secret that few (if any) other industries face the scientific, economic, and regulatory hurdles in bringing products to the people as this one does. The hurdles are there for good reason, of course. The U.S. Food and Drug Administration (FDA) and their international peers protect us all from ineffective, substandard, and even dangerous compounds, whether produced willfully by

Marketing 105
article thumbnail

Stanford study: 30% of opioid-naive Medicaid patients develop a dependency after prescription

MedCity News

A new Stanford study revealed that among Medicaid patients who had never taken an opioid, 30% developed an opioid dependency following their first prescription. The research showed that opioids that have historically marketed as “safe,” such as tramadol, actually carry quite a high addiction risk for vulnerable populations.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Parexel joins pharmacy giants in quest to boost community health clinical trials

PharmaVoice

The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.

article thumbnail

DeltaV™ Spectral PAT: Achieve Real-Time, Closed-Loop Control in PAT Manufacturing

PharmaTech

In a new podcast titled, “DeltaV™ Spectral Process Analytical Technology (PAT): Achieve Real-Time, Closed-Loop PAT in Manufacturing,” find out how embedding PAT directly into the control system enables life sciences manufacturers to take a simplified approach to achieving real-time manufacturing, compliance with confidence, greater ROI and delivery of quality treatments to market faster.

article thumbnail

6 Ways to Ensure Your Marketing Gets in Front of Generation Z

PM360

Members of Generation Z are emerging into adulthood and quickly becoming one of the most discerning, thoughtful cohorts of consumers in U.S. history. As they grow more financially independent, they will begin to use their large collective spending power to choose healthcare options that fit their lifestyle, ethics, and personal brand. In a previous post , I talked about how to tailor healthcare messaging to this technologically minded, brand-conscious, and convenience-seeking generation.

article thumbnail

Medable rolls out new decentralized trial software for speedier vaccine development

MedCity News

Medable recently launched a software solution to shorten the launch times for decentralized vaccine trials. The company says the software can reduce trial deployment timelines from more than 12 weeks on average to as short as five weeks.

Pharma 119
article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

The ‘long COVID’ nightmare: Data-driven alliance offers understanding of the lasting viral impact

PharmaVoice

A collaboration between Stanford University researchers and Komodo Health aims to advance knowledge of lingering COVID symptoms, health disparities and intervention strategies.

98
article thumbnail

Moderna files lawsuits against Pfizer and BioNTech over mRNA technology

Pharmaceutical Technology

Moderna has f iled patent infringement lawsuits in the US District Court for the District of Massachusetts and the Regional Court of Düsseldorf in Germany against Pfizer and BioNTech over messenger ribonucleic acid (mRNA) technology. Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, is said to have infringed patents filed by Moderna between 2010 and 2016 for its mRNA technology.

article thumbnail

What I Brought Home from the 2022 Chief Patient Officer Summit

PM360

Recently, industry and community patient advocacy pioneers came together for the Chief Patient Officer Summit. Though the title is rare, having a leader highly placed within a biopharmaceutical company solely responsible for integrating patient perspectives is no longer Pollyanna. In the context of the dueling, incongruous dynamics of patient empowerment, cost-sharing, and indisputable disparities, it’s strategic, ethical, and intuitive.

article thumbnail

Biden administration distributes nearly $100M to navigators for 2023 open enrollment period

MedCity News

The $98.9 million investment is going to 59 navigator organizations to help consumers find coverage during the 2023 open enrollment period. One recipient said the funding will be especially helpful as the end of the Covid-19 public health emergency nears, when a projected 15 million people will lose coverage.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Leading the industry’s next potential game-changer in drug discovery

PharmaVoice

Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.

Leads 98
article thumbnail

3D printing of starch-based tablets for personalised drug delivery

European Pharmaceutical Review

Researchers from UPV/EHU-University of the Basque Country, Spain, have successfully produced different types of starch-based pharmaceutical tablets using 3D printing. The aim of the study, published in the International Journal of Pharmaceutics , was to produce 3D printed starch-based tablets for the tailored delivery of hydrophobic drugs. Hydrophobic drugs – those that poorly water soluble – account for some 40% of marketed drugs and the 60% of the drug candidates in research, the paper notes.

article thumbnail

The Top-Performing OTC and Rx Pharma Ads Generated 56 Million Searches in 2022

PM360

Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. Amidst a fragmented Convergent TV landscape that offers consumers a multitude of ways to watch their preferred programming, linear TV is still a valuable environment for pharma advertisers.

Pharma 98
article thumbnail

Why AI is the solution for IVF accessibility

MedCity News

By augmenting the embryologist in selecting the most viable embryo, there is potential for AI to help a patient conceive in one or two cycles, reducing the inherent cost of IVF therapy, and making the treatment more accessible to diverse populations that often don’t have ease of access to treatments today.

Patients 116
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

First 90 Days: Adaptive Biotech’s Tycho Peterson

PharmaVoice

A long-time analyst, Tycho Peterson brings his business savvy to the C-suite at Adaptive, where he began as CFO in June with a knowledge of what works and what doesn't in the diagnostics space.

97
article thumbnail

Dr. B: Expanding the business model from COVID vaccines to antiviral medications

pharmaphorum

Cyrus Massoumi, founder of Dr. B, tells us about his online platform that makes physician assessment readily available to patients and provides access to COVID-19 therapeutics that may otherwise be difficult to obtain. COVID-19 antiviral medications Paxlovid (nirmatrelvir/ritonavir) and Lagevrio (molnupiravir) must be taken within five days of the onset of symptoms, but obtaining these medications within that window is difficult for some.

Medical 96
article thumbnail

From Volume-to-Value—The Critical Role of EHR

PM360

The adoption of Electronic Health Records (EHRs) had been a slow process until 2009 when federal incentives to healthcare professionals (HCPs) to switch from paper to EHR charts became available, and when HCPs were rewarded via higher payments for meeting meaningful use criteria. HCPs needed to show they could utilize a certified EHR in a meaningful way (i.e., make patient’s health information available online within a short period of time, facilitate the electronic exchange of health informatio

article thumbnail

Brain-focused Neurocrine buys a biotech to broaden its scope in hormone disorders

MedCity News

Neurocrine Biosciences is acquiring Diurnal Group, a U.K-based biotech that has commercialized two endocrine disorder drugs. Neurocrine’s top-selling product is a blockbuster drug for an involuntary muscle movement disorder.

Biopharma 118
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Moderna’s lawsuit against Pfizer and BioNTech explained in 10 quotes

PharmaVoice

The biotech says that its competitors’ COVID-19 vaccine copied proprietary mRNA technology. Here’s a breakdown of the case.

105
105
article thumbnail

Neurocrine Bio agrees $57m takeover of UK biotech Diurnal

pharmaphorum

Neurocrine Biosciences has featured on lists of potential takeover candidates for years, but has now taken the lead on a buyout of UK biotech Diurnal that if consummated will extend its therapeutic focus further into hormonal disorders. The 27.5 pence-a-share cash deal values Diurnal at around £48.3 million ($57 million), a 144% premium to the biotech’s closing share price on Friday.

Sales 95
article thumbnail

The Killer Networking Mistakes Every Medical Sales Rep Must Avoid

MedReps

Networking is a crucial part of every medical sales career. Getting to know people who work in the industry you’re representing, as well as the one that you’re selling products in, is the key to your success. However, it’s very easy to make mistakes while networking, ones that can have a highly negative impact on your career. Here are some of the most common errors, as well as ways to overcome them.

article thumbnail

Avenda Health scores $10M to personalize prostate cancer care

MedCity News

Avenda Health, an AI company focused on personalized prostate cancer care, recently closed a $10 million Series B funding round. The company’s platform seeks to personalize treatment to the patient and their specific case to preserve quality of life and prevent cancer recurrence.

Patients 114
article thumbnail

ABM Evolution: How Top Marketers Are Using Account-Based Strategies

In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.